National Institute on Aging; Notice of Closed Meetings, 57321 [E9-26688]

Download as PDF Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Notices erowe on DSK5CLS3C1PROD with NOTICES amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Training Grants. Date: November 16, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Fairmont Hotel, 2401 M Street, NW., Washington, DC 20037. Contact Person: Daniel R. Kenshalo, PhD, Scientific Review Officer, National Eye Institute, National Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892, 301–451–2020, kenshalod@nei.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Eye Institute Special Emphasis Panel; P30—Core Grant Applications for Vision Research. Date: November 23, 2009. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Anne E Schaffner, PhD, Scientific Review Officer, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. Name of Committee: National Eye Institute Special Emphasis Panel; National Eye Institute Clinical Trials UlO and Epidemiology Review. Date: November 30, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Hotel at the Chevy Chase Pavillion, 4300 Military Rd., NW., Chevy Chase Room, Washington, DC 20015. Contact Person: Samuel Rawlings, PhD, Chief, Scientific Review Branch, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300 MSC 9300, Bethesda, MD 20892–9300, 301–451–2020, rawlings@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) VerDate Nov<24>2008 14:57 Nov 04, 2009 Jkt 220001 Dated: October 28, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–26483 Filed 11–4–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): State Based Occupational Health and Safety Surveillance Grants, Program Announcement Number (PA) PAR09– 184, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Dates 8 a.m.–5 p.m., December 2, 2009 (closed). 8 a.m.–5 p.m., December 3, 2009 (closed). Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone (703) 684–5900. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘State Based Occupational Health and Safety Surveillance Grants, PAR09–184.’’ Contact Person for More Information: Mack Stiles, DDS, MPH, PhD, Scientific Review Administrator, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, 1600 Clifton Road, NE., Mailstop E–74, Atlanta, Georgia 30333; Telephone (404)498–2530. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 29, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–26672 Filed 11–4–09; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00037 Fmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel, Pathogenesis and Treatment of Tau Mediated Neurodegeneration. Date: November 30, 2009. Time: 12:15 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Alexander Parsadanian, PhD, Scientific Review Officer, National Institute on Aging, Gateway Building 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7703, Parsadaniana@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel, New Drug Toxicology to Treat Alzheimer’s Disease and Diseases. Date: December 11, 2009. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jeannette L. Johnson, PhD, Scientific Review Officer, National Institutes on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301–402–7705, Johnsonj9@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: October 30, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–26688 Filed 11–4–09; 8:45 am] BILLING CODE 4140–01–P Sfmt 4703 57321 E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 74, Number 213 (Thursday, November 5, 2009)]
[Notices]
[Page 57321]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26688]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel, Pathogenesis and Treatment of Tau Mediated Neurodegeneration.
    Date: November 30, 2009.
    Time: 12:15 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, 2C212, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Alexander Parsadanian, PhD, Scientific Review 
Officer, National Institute on Aging, Gateway Building 2C212, 7201 
Wisconsin Avenue, Bethesda, MD 20892, 301-402-7703, 
Parsadaniana@nia.nih.gov.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel, New Drug Toxicology to Treat Alzheimer's Disease and 
Diseases.
    Date: December 11, 2009.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, 2C212, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Jeannette L. Johnson, PhD, Scientific Review 
Officer, National Institutes on Aging, National Institutes of 
Health, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-
402-7705, Johnsonj9@nia.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: October 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-26688 Filed 11-4-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.